Effect of Selective Serotonin Reuptake Inhibitors in Alzheimer’s Disease with Comorbid Depression

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Drugs & Aging

• Publication date

  2012-10-11

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/s40266-012-0012-5PMID 23079957
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dose-response relationship between selective serotonin re-uptake inhibitors and injurious falls: a study in nursing home residents with dementia.

  2012cited by this paper
• Stay the course--is it justified?

  2012cited by this paper
• Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

  2011cited by this paper
• A Systematic Review and Meta‐Analysis of Placebo‐Controlled Antidepressant Studies in People with Depression and Dementia

  2011cited by this paper
• Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial.

  2011influential reference
• A critical evaluation of the cardiac toxicity of citalopram: part 2.

  2011cited by this paper
• The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

  2011cited by this paper
• Do treatment effects vary among differing baseline depression criteria in depression in Alzheimer's disease study ± 2 (DIADS‐2)?

  2011cited by this paper
• Epidemiology of Alzheimer disease

  2011cited by this paper
• Understanding and assessing adverse drug reactions.

  2011cited by this paper
• Differential Diagnosis of Depression and Alzheimer's Disease Using the Cattell-Horn-Carroll Theory

  2011cited by this paper
• A critical evaluation of the cardiac toxicity of citalopram: part 1.

  2011cited by this paper
• Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes.

  2010influential reference
• Sertraline for the treatment of depression in Alzheimer disease.

  2010influential reference
• Management of behavioral problems in Alzheimer's disease

  2010cited by this paper
• Fluoxetine reverses the memory impairment and reduction in proliferation and survival of hippocampal cells caused by methotrexate chemotherapy

  2010cited by this paper
• Psychopharmacological neuroprotection in neurodegenerative disease: assessing the preclinical data.

  2010cited by this paper
• Depression in Alzheimer's Disease. Pathophysiology, Diagnosis, and Treatment

  2010cited by this paper
• Late-life depression, mild cognitive impairment, and dementia: possible continuum?

  2010cited by this paper
• [Antidepressant use in demented elderly subjects: current data].

  2009cited by this paper
• Efficacy of SSRIs on cognition of Alzheimer's disease patients treated with cholinesterase inhibitors

  2009influential reference
• Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement

  2009cited by this paper
• Effect of a serotonin reuptake inhibitor on irritability, apathy, and psychotic symptoms in patients with Alzheimer's disease.

  2009cited by this paper
• Neuropsychological characteristics as predictors of SSRI treatment response in depressed subjects

  2008cited by this paper
• Maladie d’Alzheimer et troubles psychiatriques

  2008cited by this paper
• Depression in Alzheimer's disease: Phenomenology, clinical correlates and treatment

  2008cited by this paper
• A comparison of neurocognitive impairment in younger and older adults with major depression

  2008cited by this paper
• Efficacy of second generation antidepressants in late-life depression: a meta-analysis of the evidence.

  2008cited by this paper
• [Depression in Alzheimer's disease].

  2008cited by this paper
• Does Serotonin Augmentation Have Any Effect on Cognition and Activities of Daily Living in Alzheimer's Dementia?: A Double-Blind, Placebo-Controlled Clinical Trial

  2007cited by this paper
• Efficacy and Safety of Antidepressants for Treatment of Depression in Alzheimer's Disease: A Metaanalysis

  2007cited by this paper
• Neuropsychiatric Manifestations in Mild Cognitive Impairment: A Systematic Review of the Literature

  2007cited by this paper
• G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences

  2007cited by this paper
• American Psychiatric Association practice guideline for the treatment of patients with Alzheimer's disease and other dementias. Second edition.

  2007cited by this paper
• Management of mild to moderate Alzheimer's disease and dementia

  2007cited by this paper
• Current and Emerging Pharmacological Treatment Options for Dementia

  2006cited by this paper
• Essential Psychopharmacology: The Prescriber’s Guide

  2006cited by this paper
• [Treatment of non cognitive symptoms of Alzheimer's disease].

  2006cited by this paper
• Design of Depression in Alzheimer's Disease Study-2.

  2006cited by this paper
• Pattern of impaired working memory during major depression.

  2006cited by this paper
• Depression in Alzheimer’s disease

  2006cited by this paper
• Essential Psychopharmacology: The Prescriber's Guide

  2005cited by this paper
• Patient predictors of response to treatment of depression in Alzheimer's disease: the DIADS study

  2004cited by this paper
• Cognitive response to pharmacological treatment for depression in Alzheimer disease: secondary outcomes from the depression in Alzheimer's disease study (DIADS).

  2004cited by this paper
• Comprehensive Meta-Analysis

  2004cited by this paper
• Alzheimer disease in the US population: prevalence estimates using the 2000 census.

  2003cited by this paper
• Validity of Self-Reports in Dementia Research

  2003cited by this paper
• Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS.

  2003influential reference
• Measuring inconsistency in meta-analyses

  2003cited by this paper
• Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial.

  2002cited by this paper
• Provisional diagnostic criteria for depression of Alzheimer disease: rationale and background.

  2002cited by this paper
• Cognitive disturbance in outpatient depressed younger adults: evidence of modest impairment.

  2001cited by this paper
• A Double-Blind, Placebo-Controlled Study of Fluoxetine in Depressed Patients With Alzheimer's Disease

  2001influential reference
• Randomized, placebo-controlled, double-blind clinical trial of sertraline in the treatment of depression complicating Alzheimer's disease: initial results from the Depression in Alzheimer's Disease study.

  2000cited by this paper
• A controlled clinical trial of sertraline in the treatment of depression in nursing home patients with late-stage Alzheimer's disease.

  2000influential reference
• Variability in annual Mini-Mental State Examination score in patients with probable Alzheimer disease: a clinical perspective of data from the Consortium to Establish a Registry for Alzheimer's Disease.

  1999cited by this paper
• Agency for Health Care Policy and Research.

  1999cited by this paper
• Hyponatraemia Associated with the Use of Selective Serotonin Re-Uptake Inhibitors

  1998cited by this paper
• Diagnosing Alzheimer's Disease in the Presence of Mixed Cognitive and Affective Symptoms

  1997cited by this paper
• Cornell Scale for Depression in Dementia

  1997cited by this paper
• Assessing the quality of reports of randomized clinical trials: is blinding necessary?

  1996cited by this paper
• The Handbook of Research Synthesis

  1995cited by this paper
• Depression in Primary Care: Detection, Diagnosis, and Treatment

  1994cited by this paper
• The Handbook of Research Synthesis

  1994cited by this paper
• Depression in primary care: detection, diagnosis and treatment. Agency for Health Care Policy and Research.

  1993cited by this paper
• Depression in primary care: detection, diagnosis, and treatment. Agency for Health Care Policy and Research.

  1993cited by this paper
• DSTAT : software for the meta-analytic review of research literatures

  1992cited by this paper
• Establishing the limits of the Mini-Mental State. Examination of 'subtests'.

  1992cited by this paper
• The Mini‐Mental State Examination: A Comprehensive Review

  1992cited by this paper
• Limitation of the Mini-Mental State Examination for the Detection of Amnesia

  1992cited by this paper
• J Neuropsychiatry Clin Neurosci

  1992cited by this paper
• Detection of depressive disorder for patients receiving prepaid or fee-for-service care. Results from the Medical Outcomes Study.

  1989cited by this paper
• Endometriosis: pathophysiology, diagnosis, and treatment.

  1989cited by this paper
• Cornell Scale for Depression in Dementia.

  1988cited by this paper
• Meta-analysis in clinical trials.

  1986cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper
• The Relationship between Senile Dementia (Alzheimer Type) and Depression *

  1983cited by this paper
• [Depressive pseudodementia and Alzheimer's disease - a pilot study (author's transl)].

  1982cited by this paper
• [Depressive pseudodementia and Alzheimer's disease - a pilot study (author's transl)].

  1982cited by this paper
• The file drawer problem and tolerance for null results

  1979cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper
• A RATING SCALE FOR DEPRESSION

  1960influential reference

• Lower Plasma Serotonin is Associated with Higher Amyloid Burden, Hippocampal Atrophy, and Cognitive decline in Alzheimer’s Disease: A 24-Month Longitudinal Study

  2026cites this paper
• [Clinical guidelines «Cognitive disorders in the elderly and senile persons»].

  2025cites this paper
• SSRIs reduce plasma tau and restore dorsal raphe metabolism in Alzheimer's disease

  2025cites this paper
• Music-based therapeutic interventions for people with dementia.

  2025cites this paper
• Emerging Therapeutic Potential of Fluoxetine on Cognitive Decline in Alzheimer’s Disease: Systematic Review

  2024cites this paper
• Treating Depression in Dementia Patients: A Risk or Remedy—A Narrative Review

  2024cites this paper
• Neuropsychiatric Symptoms of Alzheimer’s Disease: An Anatomic-Genetic Framework for Treatment Development

  2023cites this paper
• A systematic review and meta-analysis on the efficacy outcomes of selective serotonin reuptake inhibitors in depression in Alzheimer’s disease

  2023cites this paper
• Putative pathological mechanisms of late-life depression and Alzheimer's Disease.

  2023cites this paper
• Depression in Major Neurodegenerative Diseases and Strokes: A Critical Review of Similarities and Differences among Neurological Disorders

  2023cites this paper
• Depressive Episodes in Patients with Newly-Diagnosed Early-Onset Dementia versus Late-Onset Dementia

  2023cites this paper
• The impact of depression on language function in individuals with Alzheimer’s disease: a pre/post-treatment design

  2023cites this paper
• Mindfulness-based stress reduction for community-dwelling older adults with subjective cognitive decline (SCD) and mild cognitive impairment (MCI) in primary care: a mixed-methods feasibility randomized control trial

  2023cites this paper
• Dietary xylitol supplement ameliorated AD related neuronal injury by regulating glucose metabolism relevant amino acids in mice.

  2022cites this paper
• Managing the Behavioral and Psychological Symptoms of Dementia

  2022cites this paper
• Long-term use of pharmacological treatment in Alzheimer’s disease: a retrospective cohort study in real-world clinical practice

  2022cites this paper
• Management of neuropsychiatric symptoms in dementia

  2022cites this paper
• Depression and Dementia in Older Adults: A Neuropsychological Review

  2021cites this paper
• Protective Effects of Anti-depressant Citalopram Against Abnormal APP Processing and Amyloid Beta-induced Mitochondrial Dynamics, Biogenesis, Mitophagy and Synaptic Toxicities in Alzheimer's Disease.

  2021cites this paper
• Clinical Guidelines for Cognitive Disorders in Elderly and Older Patients

  2021cites this paper
• Cognitive Impairment Evaluation and Management

  2020cites this paper
• Analysis of risk factors for depression in Alzheimer’s disease patients

  2020cites this paper
• Acetylcholinesterase: The “Hub” for Neurodegenerative Diseases and Chemical Weapons Convention

  2020cites this paper
• Neuropsychiatric Aspects of Alzheimer Dementia: From Mechanism to Treatment.

  2020cites this paper
• Occupational therapist-led mindfulness-based stress reduction for older adults living with subjective cognitive decline or mild cognitive impairment in primary care: a feasibility randomised control trial protocol

  2020cites this paper
• Advances in Management of Neuropsychiatric Syndromes in Neurodegenerative Diseases

  2019cites this paper
• The effect of selective serotonin reuptake inhibitors on cognitive function in patients with Alzheimer’s disease and vascular dementia: focusing on fluoxetine with long follow-up periods

  2019cites this paper
• University of Birmingham Depression in Alzheimer's disease

  2019cites this paper
• The Effect of Antidepressants on Depression After Traumatic Brain Injury: A Meta-analysis

  2019cites this paper
• Examining the Complicated Relationship Between Depressive Symptoms and Cognitive Impairment in Preclinical Alzheimer Disease

  2019cites this paper
• RACGP- aged care clinical guide (Silver Book) Part A

  2019cites this paper
• Behavioral and psychological symptoms in Alzheimer's dementia and vascular dementia.

  2019cites this paper
• The Hyperactivity–Impulsivity–Irritiability–Disinhibition–Aggression–Agitation Domain in Alzheimer’s Disease: Current Management and Future Directions

  2019cites this paper
• Pharmacological Treatment of Depression in Alzheimer’s Disease: A Challenging Task

  2019cites this paper
• Depression in Alzheimer’s Disease: An Alternative Role for Selective Serotonin Reuptake Inhibitors?

  2019cites this paper
• Major Neurocognitive Disorder with Behavioral Disturbance (Behavioral and Psychological Symptoms of Dementia—BPSD)

  2019cites this paper
• Deep Brain Stimulation of Frontal Lobe Networks to Treat Alzheimer’s Disease

  2018cites this paper
• Receptive Music Therapy Is More Effective than Interactive Music Therapy to Relieve Behavioral and Psychological Symptoms of Dementia: A Systematic Review and Meta-Analysis.

  2018cites this paper
• Pharmacotherapy for the treatment of depression in patients with alzheimer’s disease: a treatment-resistant depressive disorder

  2018cites this paper
• Agmatine attenuates depressive‐like behavior and hippocampal oxidative stress following amyloid &bgr; (A&bgr;1–40) administration in mice

  2018cites this paper
• Receptive music interventions improve apathy and depression in elderly patients with dementia

  2018cites this paper
• Association of the Centers for Medicare & Medicaid Services’ National Partnership to Improve Dementia Care With the Use of Antipsychotics and Other Psychotropics in Long-term Care in the United States From 2009 to 2014

  2018cites this paper
• ATP-sensitive potassium-channel inhibitor glibenclamide attenuates HPA axis hyperactivity, depression- and anxiety-related symptoms in a rat model of Alzheimer's disease.

  2018cites this paper
• Neurobiological links between depression and AD: The role of TGF‐&bgr;1 signaling as a new pharmacological target

  2018cites this paper
• Development of an intervention to improve the management of behavioural and psychological symptoms of dementia in general practice in Ireland

  2018cites this paper
• Antidepressants for treating depression in dementia.

  2018cites this paper
• Pharmacotherapy of Alzheimer disease and neuropsychiatric symptoms of dementia

  2018cites this paper
• Farmakoterapie Alzheimerovy demence a přidružených neuropsychiatrických symptomů – 2. část

  2018cites this paper
• Meta-analysis of psychosocial interventions for people with dementia and anxiety or depression

  2018cites this paper
• Music-based therapeutic interventions for people with dementia.

  2018cites this paper
• The Use of Aroma-acupoint Therapy and Aromatherapy to TreatDepression in Dementia Patients with Severe Cognitive Impairment

  2017cites this paper
• Approaches to Behavioral Problems in Dementia

  2017cites this paper
• Music-based therapeutic interventions for people with dementia.

  2017cites this paper
• Management of Neuropsychiatric Symptoms in Neurocognitive Disorders.

  2017cites this paper
• A common challenge in older adults: Classification, overlap, and therapy of depression and dementia

  2017cites this paper
• The impact of a mindfulness based cognitive therapy group for depression in people with dementia attending memory clinics : a feasibility randomised controlled trial

  2017cites this paper
• Neuropsychiatric signs and symptoms of Alzheimer's disease: New treatment paradigms

  2017cites this paper
• What is the therapeutic value of antidepressants in dementia? A narrative review

  2017cites this paper
• Neural activity, memory, and dementias: serotonergic markers

  2017cites this paper
• Good Intentions, But What About Unintended Consequences?

  2017cites this paper
• Rezente Evidenz zur medikamentösen Therapie von psychischen und Verhaltenssymptomen bei Alzheimer-Demenz

  2016cites this paper
• Drug Therapy for Behavioral and Psychological Symptoms of Dementia

  2016cites this paper
• The Treatment of Behavioral and Psychological Symptoms of Dementia: Weighing Benefits and Risks.

  2016cites this paper
• Treatment of behavioral and psychological symptoms of dementia: a systematic review.

  2016influential citation
• The effect of treatment with selective serotonin reuptake inhibitors in comparison to placebo in the progression of dementia: a systematic review and meta-analysis.

  2016cites this paper
• Psychiatric Aspects of Dementia

  2016cites this paper
• Differences in Depressive Patterns According to Disease Severityin Early-Onset Alzheimer’s Disease

  2016cites this paper
• Benefits of Deep Transcranial Magnetic Stimulation in Alzheimer Disease: Case Series

  2016influential citation
• Alzheimer's Disease and Autistic Spectrum Disorder: Is there any Association?

  2016cites this paper
• Clinical practice guidelines for dementia in Australia

  2016cites this paper
• Multicenter, randomized, placebo‐controlled, double‐blind clinical trial of escitalopram on the progression‐delaying effects in Alzheimer's disease

  2016cites this paper
• Update on SSRI Treatment for Neuropsychiatric Symptoms of Dementia

  2016cites this paper
• Pharmacological management of behavioural and psychological symptoms of dementia

  2016cites this paper
• Screening and evaluation of natural compounds for therapeutic application in Alzheimer's disease

  2016cites this paper
• The Effect of Escitalopram on Mood and Cognition in Depressive Alzheimer’s Disease Subjects

  2016cites this paper
• Microglial dysfunction connects depression and Alzheimer's disease.

  2016cites this paper
• Serotonergic drugs for the treatment of neuropsychiatric symptoms in dementia

  2016cites this paper
• Hippocampal neurogenesis: Learning to remember.

  2016cites this paper
• Depression

  2015cites this paper
• Critical role of somatostatin receptor 2 in the vulnerability of the central noradrenergic system: new aspects on Alzheimer’s disease

  2015cites this paper
• Influence of sex and stress exposure across the lifespan on endophenotypes of depression: focus on behavior, glucocorticoids, and hippocampus

  2015cites this paper
• Is Dysregulation of the HPA-Axis a Core Pathophysiology Mediating Co-Morbid Depression in Neurodegenerative Diseases?

  2015cites this paper
• National Institute of Mental Health Depression of Alzheimer Disease : assessment and diagnostic validity studies using depression scales developed for older adults

  2015influential citation
• Catecholamine-Based Treatment in AD Patients: Expectations and Delusions

  2015cites this paper
• Depressive-Like Behavior Is Paired to Monoaminergic Alteration in a Murine Model of Alzheimer’s Disease

  2015cites this paper
• Principles and management of neuropsychiatric symptoms in Alzheimer’s dementia

  2015cites this paper
• Assessment and management of behavioral and psychological symptoms of dementia

  2015cites this paper
• Depression and dementia. A review

  2015cites this paper
• Evaluation and management of the elderly patient presenting with cognitive complaints.

  2015cites this paper
• Neuroanatomical correlates of late-life depression and associated cognitive changes.

  2015cites this paper
• Slowing the progression of Alzheimer's disease; what works?

  2015cites this paper
• Depression in Alzheimer's Disease: Epidemiology, Mechanisms, and Management

  2014cites this paper
• Management of Behavioral and Psychological Symptoms of Dementia.

  2014cites this paper
• Contribution of neural cell death to depressive phenotypes of streptozotocin-induced diabetic mice

  2014cites this paper
• Management of Behavioral and Psychological Symptoms of Dementia

  2014cites this paper
• Successful therapies for Alzheimer’s disease: why so many in animal models and none in humans?

  2014cites this paper
• Neurotoxic Saboteurs: Straws that Break the Hippo’s (Hippocampus) Back Drive Cognitive Impairment and Alzheimer’s Disease

  2013cites this paper
• Pharmacological interventions ( antidepressants ) for people with dementia who have associated depression

  year unknowncites this paper